Skip to main content

Medirom Healthcare Technologies, Inc. (MRM)

NASDAQ: MRM · IEX Real-Time Price · USD
6.80 -0.12 (-1.73%)
Dec 1, 2021 10:41 AM EST - Market open

Company Description

MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare.

The Relaxation Salon segment own, develops, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology.

As of April 30, 2021, this segment operated 301 relaxation salons under the Re.Ra.Ku and Ruam Ruam brand. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, its internally-developed on-demand health monitoring smartphone application; MOTHER Tracker for fitness applications; and preventative healthcare services utilizing its digital application and devices.

MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques located in the Odaiba area in Tokyo.

The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

Medirom Healthcare Technologies, Inc.
CountryUnited States
Founded2000
IPO DateDec 29, 2020
IndustryPersonal Services
SectorConsumer Cyclical
Employees171

Contact Details

Address:
Tradepia Odaiba
Tokyo 135-0091
Japan
Phone81 3 6721 7364
Websitemedirom.co.jp

Stock Details

Ticker SymbolMRM
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyJPY
IPO Price$15.00
CIK Code1819704

Key Executives

NamePosition
Kouji EguchiChief Executive Officer and Representative Director
Fumitoshi FujiwaraChief Financial Officer and Director
Akira AokiExecutive Officer and Chief Medical Officer

Latest SEC Filings

DateTypeTitle
Nov 19, 20216-KReport of foreign issuer [Rules 13a-16 and 15d-16]
Nov 8, 20216-KReport of foreign issuer [Rules 13a-16 and 15d-16]
Nov 3, 20216-KReport of foreign issuer [Rules 13a-16 and 15d-16]
Oct 20, 20216-KReport of foreign issuer [Rules 13a-16 and 15d-16]
Sep 24, 20216-KReport of foreign issuer [Rules 13a-16 and 15d-16]
Sep 22, 20216-KReport of foreign issuer [Rules 13a-16 and 15d-16]
Aug 19, 20216-KReport of foreign issuer [Rules 13a-16 and 15d-16]
Jul 19, 20216-KReport of foreign issuer [Rules 13a-16 and 15d-16]
Jun 22, 20216-KReport of foreign issuer [Rules 13a-16 and 15d-16]
Jun 8, 20216-KReport of foreign issuer [Rules 13a-16 and 15d-16]
View All SEC Filings